Detalles de la búsqueda
1.
Discovery of high-affinity BCL6-binding peptide and its structure-activity relationship.
Biochem Biophys Res Commun
; 482(2): 310-316, 2017 Jan 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-27856253
2.
Discovery of a novel B-cell lymphoma 6 (BCL6)-corepressor interaction inhibitor by utilizing structure-based drug design.
Bioorg Med Chem
; 25(17): 4876-4886, 2017 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28760529
3.
Discovery of 6-[5-(4-fluorophenyl)-3-methyl-pyrazol-4-yl]-benzoxazin-3-one derivatives as novel selective nonsteroidal mineralocorticoid receptor antagonists.
Bioorg Med Chem
; 22(19): 5428-45, 2014 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-25187277
4.
Design, synthesis, and structure-activity relationships of dihydrofuran-2-one and dihydropyrrol-2-one derivatives as novel benzoxazin-3-one-based mineralocorticoid receptor antagonists.
Bioorg Med Chem
; 21(19): 5983-94, 2013 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-23958516
5.
Novel acyl coenzyme A: diacylglycerol acyltransferase 1 inhibitors-synthesis and biological activities of N-(substituted heteroaryl)-4-(substituted phenyl)-4-oxobutanamides.
Chem Pharm Bull (Tokyo)
; 58(5): 673-9, 2010 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-20460795
6.
Coenzyme A: diacylglycerol acyltransferase 1 inhibitor ameliorates obesity, liver steatosis, and lipid metabolism abnormality in KKAy mice fed high-fat or high-carbohydrate diets.
Eur J Pharmacol
; 640(1-3): 243-9, 2010 Aug 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-20478303
Resultados
1 -
6
de 6
1
Próxima >
>>